Intelligent Bio Solutions (NASDAQ:INBS) and Sanuwave Health (NASDAQ:SNWV) Head-To-Head Review

Sanuwave Health (NASDAQ:SNWV) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Profitability

This table compares Sanuwave Health and Intelligent Bio Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sanuwave Health	32.38%	1,728.10%	39.04%
Intelligent Bio Solutions	-294.88%	-175.35%	-91.25%

Volatility & Risk

Sanuwave Health has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.31, meaning that its share price is 331% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and target prices for Sanuwave Health and Intelligent Bio Solutions, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanuwave Health	2	0	1	0	1.67
Intelligent Bio Solutions	1	1	0	0	1.50

Sanuwave Health presently has a consensus price target of $47.00, indicating a potential upside of 820.13%. Given Sanuwave Health’s stronger consensus rating and higher probable upside, analysts clearly believe Sanuwave Health is more favorable than Intelligent Bio Solutions.

Earnings and Valuation

This table compares Sanuwave Health and Intelligent Bio Solutions”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanuwave Health	$44.05 million	1.00	$11.81 million	$0.24	21.28
Intelligent Bio Solutions	$4.22 million	1.34	-$12.43 million	($9.02)	-0.19

Sanuwave Health has higher revenue and earnings than Intelligent Bio Solutions. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Sanuwave Health, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

42.5% of Sanuwave Health shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 14.4% of Sanuwave Health shares are owned by company insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Sanuwave Health beats Intelligent Bio Solutions on 12 of the 14 factors compared between the two stocks.

About Sanuwave Health

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company’s lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body’s normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.